NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition
Go back to NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition| NEOGENOMICS (NASDAQ: NEO) | Delayed: 11.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.20 | 52 Week High | $9.54 | |||
| Open | $11.20 | 52 Week Low | $5.49 | |||
| Day High | $11.20 | P/E | 280.00 | |||
| Day Low | $11.20 | EPS | $0.04 | |||
| Volume | 2,331 | |||||
